Literature DB >> 2630364

Terrien's disease: clinical and ultrastructural studies, five case reports.

Y Pouliquen1, P Dhermy, G Renard, L Goichot-Bonnat, G Foster, M Savoldelli.   

Abstract

Terrien's disease occurs in middle-aged patients and is characterised by an insidious thinning of the cornea near the limbus. In most cases, this results in a peripheral ectasia associated with a severe degree of astigmatism. Inflammatory signs are rarely observed in this marginal corneal degeneration which is of unknown aetiology. Electron and light microscopic studies have been performed on five specimens from penetrating keratoplasties. Anatomical and clinical correlations showed the marked marginal degenerations of the corneal stroma to be consistently associated with lipid deposits, but without inflammatory cell infiltrate. These changes are in agreement with previous reported pathological descriptions of Terrien's disease.

Entities:  

Mesh:

Year:  1989        PMID: 2630364     DOI: 10.1038/eye.1989.123

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  4 in total

1.  Bilateral Mooren's ulcer in six patients: diagnosis, surgery and histopathology.

Authors:  Christos D Kalogeropoulos; Vassiliki D Malamou-Mitsi; Miltiadis B Aspiotis; Konstantinos G Psilas
Journal:  Int Ophthalmol       Date:  2004-01       Impact factor: 2.031

2.  [Pseudotumor of the cornea in childhood].

Authors:  G Avgitidou; A Zhivov; L M Heindl; C Cursiefen
Journal:  Ophthalmologe       Date:  2014-11       Impact factor: 1.059

3.  Patch Graft for Corneal Perforation Following Trivial Trauma in Bilateral Terrien's Marginal Degeneration.

Authors:  Merle Fernandes; Divya Vira
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

4.  Spontaneous corneal perforation in Terrien's marginal degeneration in childhood: A case report.

Authors:  Junkyu Chung; Kyung Hyun Jin; Jaheon Kang; Tae Gi Kim
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.